pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: a translational subgroup analysis from AIO-PK0104

The role of pERK, pAKT and p53 as biomarkers in patients with advanced pancreatic cancer has not yet been defined.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ormanns, Steffen (VerfasserIn) , Siveke, Jens T. (VerfasserIn) , Heinemann, Volker (VerfasserIn) , Haas, Michael (VerfasserIn) , Sipos, Bence (VerfasserIn) , Schlitter, Anna Melissa (VerfasserIn) , Esposito, Irene (VerfasserIn) , Jung, Andreas (VerfasserIn) , Laubender, Rüdiger P. (VerfasserIn) , Kruger, Stephan (VerfasserIn) , Vehling-Kaiser, Ursula (VerfasserIn) , Winkelmann, Cornelia (VerfasserIn) , Fischer von Weikersthal, Ludwig (VerfasserIn) , Clemens, Michael R. (VerfasserIn) , Gauler, Thomas C. (VerfasserIn) , Märten, Angela (VerfasserIn) , Geißler, Michael (VerfasserIn) , Greten, Tim F. (VerfasserIn) , Kirchner, Thomas (VerfasserIn) , Boeck, Stefan (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 28 August 2014
In: BMC cancer
Year: 2014, Jahrgang: 14
ISSN:1471-2407
DOI:10.1186/1471-2407-14-624
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/1471-2407-14-624
Verlag, lizenzpflichtig, Volltext: https://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-14-624
Volltext
Verfasserangaben:Steffen Ormanns, Jens T. Siveke, Volker Heinemann, Michael Haas, Bence Sipos, Anna Melissa Schlitter, Irene Esposito, Andreas Jung, Rüdiger P. Laubender, Stephan Kruger, Ursula Vehling-Kaiser, Cornelia Winkelmann, Ludwig Fischer von Weikersthal, Michael R. Clemens, Thomas C. Gauler, Angela Märten, Michael Geissler, Tim F. Greten, Thomas Kirchner and Stefan Boeck

MARC

LEADER 00000caa a2200000 c 4500
001 1729056881
003 DE-627
005 20230126153819.0
007 cr uuu---uuuuu
008 200908s2014 xx |||||o 00| ||eng c
024 7 |a 10.1186/1471-2407-14-624  |2 doi 
035 |a (DE-627)1729056881 
035 |a (DE-599)KXP1729056881 
035 |a (OCoLC)1341358908 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Ormanns, Steffen  |d 1982-  |e VerfasserIn  |0 (DE-588)1188594117  |0 (DE-627)1667545418  |4 aut 
245 1 0 |a pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer  |b a translational subgroup analysis from AIO-PK0104  |c Steffen Ormanns, Jens T. Siveke, Volker Heinemann, Michael Haas, Bence Sipos, Anna Melissa Schlitter, Irene Esposito, Andreas Jung, Rüdiger P. Laubender, Stephan Kruger, Ursula Vehling-Kaiser, Cornelia Winkelmann, Ludwig Fischer von Weikersthal, Michael R. Clemens, Thomas C. Gauler, Angela Märten, Michael Geissler, Tim F. Greten, Thomas Kirchner and Stefan Boeck 
246 3 3 |a pERK, pAKT and p fifty-three as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer 
264 1 |c 28 August 2014 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 09.09.2020 
520 |a The role of pERK, pAKT and p53 as biomarkers in patients with advanced pancreatic cancer has not yet been defined. 
700 1 |a Siveke, Jens T.  |e VerfasserIn  |4 aut 
700 1 |a Heinemann, Volker  |e VerfasserIn  |4 aut 
700 1 |a Haas, Michael  |e VerfasserIn  |4 aut 
700 1 |a Sipos, Bence  |e VerfasserIn  |4 aut 
700 1 |a Schlitter, Anna Melissa  |e VerfasserIn  |4 aut 
700 1 |a Esposito, Irene  |e VerfasserIn  |4 aut 
700 1 |a Jung, Andreas  |e VerfasserIn  |4 aut 
700 1 |a Laubender, Rüdiger P.  |e VerfasserIn  |4 aut 
700 1 |a Kruger, Stephan  |e VerfasserIn  |4 aut 
700 1 |a Vehling-Kaiser, Ursula  |e VerfasserIn  |4 aut 
700 1 |a Winkelmann, Cornelia  |e VerfasserIn  |4 aut 
700 1 |a Fischer von Weikersthal, Ludwig  |e VerfasserIn  |4 aut 
700 1 |a Clemens, Michael R.  |e VerfasserIn  |4 aut 
700 1 |a Gauler, Thomas C.  |e VerfasserIn  |4 aut 
700 1 |a Märten, Angela  |d 1968-  |e VerfasserIn  |0 (DE-588)122240103  |0 (DE-627)081822456  |0 (DE-576)293167931  |4 aut 
700 1 |a Geißler, Michael  |d 1964-  |e VerfasserIn  |0 (DE-588)133573222  |0 (DE-627)548763305  |0 (DE-576)299942767  |4 aut 
700 1 |a Greten, Tim F.  |e VerfasserIn  |4 aut 
700 1 |a Kirchner, Thomas  |e VerfasserIn  |4 aut 
700 1 |a Boeck, Stefan  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t BMC cancer  |d London : BioMed Central, 2001  |g 14(2014), Artikel-Nummer 624, 10 Seiten  |h Online-Ressource  |w (DE-627)326643710  |w (DE-600)2041352-X  |w (DE-576)107014645  |x 1471-2407  |7 nnas  |a pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer a translational subgroup analysis from AIO-PK0104 
773 1 8 |g volume:14  |g year:2014  |g extent:10  |a pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer a translational subgroup analysis from AIO-PK0104 
856 4 0 |u https://doi.org/10.1186/1471-2407-14-624  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-14-624  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200908 
993 |a Article 
994 |a 2014 
998 |g 122240103  |a Märten, Angela  |m 122240103:Märten, Angela  |d 50000  |e 50000PM122240103  |k 0/50000/  |p 16 
999 |a KXP-PPN1729056881  |e 3747489362 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"family":"Ormanns","given":"Steffen","roleDisplay":"VerfasserIn","display":"Ormanns, Steffen","role":"aut"},{"display":"Siveke, Jens T.","roleDisplay":"VerfasserIn","role":"aut","family":"Siveke","given":"Jens T."},{"display":"Heinemann, Volker","roleDisplay":"VerfasserIn","role":"aut","family":"Heinemann","given":"Volker"},{"role":"aut","display":"Haas, Michael","roleDisplay":"VerfasserIn","given":"Michael","family":"Haas"},{"roleDisplay":"VerfasserIn","display":"Sipos, Bence","role":"aut","family":"Sipos","given":"Bence"},{"family":"Schlitter","given":"Anna Melissa","display":"Schlitter, Anna Melissa","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Irene","family":"Esposito","role":"aut","display":"Esposito, Irene","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Jung, Andreas","roleDisplay":"VerfasserIn","given":"Andreas","family":"Jung"},{"role":"aut","display":"Laubender, Rüdiger P.","roleDisplay":"VerfasserIn","given":"Rüdiger P.","family":"Laubender"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Kruger, Stephan","given":"Stephan","family":"Kruger"},{"given":"Ursula","family":"Vehling-Kaiser","role":"aut","display":"Vehling-Kaiser, Ursula","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","display":"Winkelmann, Cornelia","role":"aut","family":"Winkelmann","given":"Cornelia"},{"family":"Fischer von Weikersthal","given":"Ludwig","roleDisplay":"VerfasserIn","display":"Fischer von Weikersthal, Ludwig","role":"aut"},{"display":"Clemens, Michael R.","roleDisplay":"VerfasserIn","role":"aut","family":"Clemens","given":"Michael R."},{"display":"Gauler, Thomas C.","roleDisplay":"VerfasserIn","role":"aut","family":"Gauler","given":"Thomas C."},{"given":"Angela","family":"Märten","role":"aut","roleDisplay":"VerfasserIn","display":"Märten, Angela"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Geißler, Michael","given":"Michael","family":"Geißler"},{"family":"Greten","given":"Tim F.","roleDisplay":"VerfasserIn","display":"Greten, Tim F.","role":"aut"},{"family":"Kirchner","given":"Thomas","roleDisplay":"VerfasserIn","display":"Kirchner, Thomas","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Boeck, Stefan","given":"Stefan","family":"Boeck"}],"title":[{"title":"pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer","subtitle":"a translational subgroup analysis from AIO-PK0104","title_sort":"pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer"}],"note":["Gesehen am 09.09.2020"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1729056881","language":["eng"],"titleAlt":[{"title":"pERK, pAKT and p fifty-three as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer"}],"name":{"displayForm":["Steffen Ormanns, Jens T. Siveke, Volker Heinemann, Michael Haas, Bence Sipos, Anna Melissa Schlitter, Irene Esposito, Andreas Jung, Rüdiger P. Laubender, Stephan Kruger, Ursula Vehling-Kaiser, Cornelia Winkelmann, Ludwig Fischer von Weikersthal, Michael R. Clemens, Thomas C. Gauler, Angela Märten, Michael Geissler, Tim F. Greten, Thomas Kirchner and Stefan Boeck"]},"origin":[{"dateIssuedDisp":"28 August 2014","dateIssuedKey":"2014"}],"id":{"eki":["1729056881"],"doi":["10.1186/1471-2407-14-624"]},"physDesc":[{"extent":"10 S."}],"relHost":[{"id":{"issn":["1471-2407"],"eki":["326643710"],"zdb":["2041352-X"]},"origin":[{"publisher":"BioMed Central ; Springer","dateIssuedKey":"2001","dateIssuedDisp":"2001-","publisherPlace":"London ; Berlin ; Heidelberg"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"BMC cancer","title":"BMC cancer"}],"part":{"text":"14(2014), Artikel-Nummer 624, 10 Seiten","volume":"14","extent":"10","year":"2014"},"pubHistory":["1.2001 -"],"language":["eng"],"recId":"326643710","note":["Gesehen am 22.05.20"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer a translational subgroup analysis from AIO-PK0104BMC cancer"}]} 
SRT |a ORMANNSSTEPERKPAKTAN2820